GL1X · GenesisL1 explorer

MolNFT v1 · #168869 · protein

Human JAK2 JH1 domain in complex with protac-intermediate linker handle 4

6WTQ · Tyrosine-protein kinase JAK2: “Human JAK2 JH1 domain in complex with protac-intermediate linker handle 4”. X-ray diffraction, 1 ligand (U8J), 2 pockets (best druggability 0.48). MolNFT v1 #168869 on GenesisL1: 3D structure, binding…

PDB
6WTQ
Type
protein
Length
265 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.10.2
UniProt
O60674
Ligands
U8J
Pockets
2 · best druggability 0.48

Structure

x-ray diffraction · 1 distinct chain · 49% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK2 (EC 2.7.10.2)protein26549% helix, 17% strandO60674

Ligands and binding sites

  • U8J · N-methyl-4-{[4-(1-propyl-1H-pyrazol-4-yl)-7H-pyrrolo[2, 3-d]pyrimidin-2-yl]amino}benzamide · ligand · chains A
  • TRS · 2-amino-2-hydroxymethyl-propane-1,3-diol · additive · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11430.480.7720U8J
2910.350.7520empty

Modifications

Observed in the structure: 2 modified (phosphorylation).

Compared structures

  • 6WTQ · Human JAK2 JH1 domain in complex with PROTAC-intermediate linker handle 4 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.